Stock Spotlight: Monash IVF Group Limited (ASX:MVF)
This week's Stock Spotlight is ASX-listed Monash IVF Group Limited.
About Monash IVF Group Limited.
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Cremorne, Australia.
Key Stats
Key Stats
Source: Yahoo Finance, ASX. Data as of 18/08/25.
Price Performance
Growth Potential
- Trading below our revised valuation (which forecast little to no growth over the near-term) but given the recent Brisbane incident we believe investors will be cautious jumping back into this name immediately.
- We would argue the current price is already largely factoring in a material structural damage to MVF’s share price.
- High barriers to entry with unique expertise and assets. 40-year heritage of leadership in science and innovation in ARS and women’s imaging, coupled with the depth of experience from the doctors and clinical team which will continue to underpin MVF’s future growth and maintain treatment success rates.
- Aging Australian population and increased age of mothers (especially with the trend of more females choosing career over family until their early thirties) will provide favorable demographic tailwinds.
- Potential earnings diversification and growth via international expansion and increased presence in diagnostics.
- Potential growth from genetic carrier screening.
Key Risks
- Brisbane incident leads to material reputation damage over the long-term leading to lower patient registrations and human capital moving to competitors.
- Regulatory risk as changes in government funding may increase patient’s out-of-pocket expenses and thereby volume demand.
- Fluctuations in the availability and size of Medicare rebates may negatively influence the number of IVF cycles administered and overall industry revenue.
- The Australian market does not rebound following this period of downturn. Population of males and females with fertility problems decline.
- Loss of key specialists.
- Loss of market share especially to low-cost providers, with one already appearing in Victoria.
- Weakening economic activity resulting in increased unemployment leading to less disposable income to be spent in IVF treatment.
- Execution of international forays into Malaysia goes poorly.
Subscribe to our newsletter
Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.
Speak to an Advisor
The RBA lifted the cash rate to 4.85% in a split vote. Here’s how higher rates flow through ASX sectors, company earnings, dividends and valuations.
Inside Anthropic’s IPO filing: explore its soaring revenue, computing commitments, reported losses and governance structure, and what the disclosures mean for investors.
Big Tech reports next week. Learn how to read earnings releases and filings, and what to look for in AI spending, cloud growth, cash flow and guidance.
Understand how AI investment could affect global financial stability, as the IMF and RBA warn of rising debt, market concentration and funding risks.
Firmus’ proposed mega-IPO puts a spotlight on the cost, capital intensity and risks of building AI infrastructure as investors weigh the next phase of the AI boom.
About Electro Optic Systems Holdings Ltd. Electro Optic Systems Holdings Limited engages in the development, manufacture, and sale of telescopes and dome enclosures, laser satellite tracking systems, remote weapon systems, and high laser weapon. It operates through Defense Systems and Space Systems segments. The company develops, manufactures, and markets fire control, surveillance, weapon systems, and high energy laser to military customers. It also provides passive optical and laser sensing equipment; optical, microwave and on-the-move radio and satellite products; and laser-based surveillance systems with space tracking capability. In addition, the company offers counter-drone, firepower, force protection, and UGV and marine lethality systems, as well as high energy laser weapon; optical tracking systems, space control, space domain awareness, satellite laser ranging, space sustainability, and precision optics. It operates in Australia, the United States, Singapore, the United Arab Emirates, the United Kingdom, New Zealand, the Netherlands, North America, Germany, and rest of Europe. Electro Optic Systems Holdings Limited was founded in 1983 and is based in Symonston, Australia. Source: EODHD Key Stats
About Liontown Ltd. Liontown Limited engages in the exploration, evaluation, and development of mineral properties in Australia. It primarily explores for lithium, gold, and nickel deposits. The company's flagship property is the Kathleen Valley lithium project located in Perth, Western Australia. The company was formerly known as Liontown Resources Limited and change its name to Liontown Limited in November 2025. Liontown Limited was incorporated in 2006 and is headquartered in West Perth, Australia. Source: EODHD Key Stats
The RBA has raised rates to 4.60% as inflation pressures persist. Explore the impact of energy costs, AI demand and the key signals investors should watch next.
Discover how advances in genomics, AI, diagnostics and gene editing are creating a broader healthcare opportunity and where commercial value is emerging.
The AI trade is being forced to rethink the pace of progress. Here is what investors should watch across Nvidia, chips, AI spending, software and adoption.
